Intraindividual variability of the bioavailability of low dose methotrexate after oral administration in rheumatoid arthritis.

Por Lebbe, C, Beyeler, C, Gerber, N J, Reichen, J
Publicado em 1994

Molecular analysis of clonality in Kaposi's sarcoma.

Por Delabesse, E, Oksenhendler, E, Lebbé, C, Vérola, O, Varet, B, Turhan, A G
Publicado em 1997

Aphthous ulcers in HIV-infected patients: treatment with thalidomide.

Por Strazzi, S, Lebbe, C, Geoffray, C, Ablon, G, Morel, P, Verola, O, Molina, J M
Publicado em 1992

Four-year survival rates for patients with metastatic melanoma who received ipilimumab in phase II clinical trials

Por Wolchok, J. D., Weber, J. S., Maio, M., Neyns, B., Harmankaya, K., Chin, K., Cykowski, L., de Pril, V., Humphrey, R., Lebbé, C.
Publicado em 2013

Sorafenib in advanced melanoma: a critical role for pharmacokinetics?

Por Pécuchet, N, Lebbe, C, Mir, O, Billemont, B, Blanchet, B, Franck, N, Viguier, M, Coriat, R, Tod, M, Avril, M-F, Goldwasser, F
Publicado em 2012

Survival follow-up and ipilimumab retreatment of patients with advanced melanoma who received ipilimumab in prior phase II studies

Por Lebbé, C., Weber, J. S., Maio, M., Neyns, B., Harmankaya, K., Hamid, O., O'Day, S. J., Konto, C., Cykowski, L., McHenry, M. B., Wolchok, J. D.
Publicado no Ann Oncol (2014)

PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French...

Por Soufir, N, Gerard, B, Portela, M, Brice, A, Liboutet, M, Saiag, P, Descamps, V, Kerob, D, Wolkenstein, P, Gorin, I, Lebbe, C, Dupin, N, Crickx, B, Basset-Seguin, N, Grandchamp, B
Publicado em 2006

Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure

Por Matichard, E, Verpillat, P, Meziani, R, Gerard, B, Descamps, V, Legroux, E, Burnouf, M, Bertrand, G, Bouscarat, F, Archimbaud, A, Picard, C, Ollivaud, L, Basset-Seguin, N, Kerob, D, Lanternier, G, Lebbe, C, Crickx, B, Grandchamp, B, Soufir, N
Publicado em 2004

Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma

Por Soufir, N, Lacapere, J J, Bertrand, G, Matichard, E, Meziani, R, Mirebeau, D, Descamps, V, Gérard, B, Archimbaud, A, Ollivaud, L, Bouscarat, F, Baccard, M, Lanternier, G, Saïag, P, Lebbé, C, Basset-Seguin, N, Crickx, B, Cave, H, Grandchamp, B
Publicado em 2004

First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma

Por Le Tourneau, C, Dreno, B, Kirova, Y, Grob, J J, Jouary, T, Dutriaux, C, Thomas, L, Lebbé, C, Mortier, L, Saiag, P, Avril, M F, Maubec, E, Joly, P, Bey, P, Cosset, J M, Sun, J S, Asselain, B, Devun, F, Marty, M E, Dutreix, M
Publicado no Br J Cancer (2016)

Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy

Por Eggermont, A.M.M., Chiario-Sileni, V., Grob, J.-J., Dummer, R., Wolchok, J.D., Schmidt, H., Hamid, O., Robert, C., Ascierto, P.A., Richards, J.M., Lebbé, C., Ferraresi, V., Smylie, M., Weber, J.S., Maio, M., Bastholt, L., Mortier, L., Thomas, L., Tahir, S., Hauschild, A., Hassel, J.C., Hodi, F.S., Taitt, C., de Pril, V., de Schaetzen, G., Suciu, S., Testori, A.
Publicado no N Engl J Med (2016)

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

Por Wolchok, J.D., Chiarion-Sileni, V., Gonzalez, R., Rutkowski, P., Grob, J.-J., Cowey, C.L., Lao, C.D., Wagstaff, J., Schadendorf, D., Ferrucci, P.F., Smylie, M., Dummer, R., Hill, A., Hogg, D., Haanen, J., Carlino, M.S., Bechter, O., Maio, M., Marquez-Rodas, I., Guidoboni, M., McArthur, G., Lebbé, C., Ascierto, P.A., Long, G.V., Cebon, J., Sosman, J., Postow, M.A., Callahan, M.K., Walker, D., Rollin, L., Bhore, R., Hodi, F.S., Larkin, J.
Publicado no N Engl J Med (2017)